New Pathways for Innovation and Transformation of Local Pharmaceutical Companies
INNOVATION announced it will acquire 100% equity in CSPC Baike for up to RMB 7.6 billion, 10% in cash and 90% in shares.
December 20, 2024
by Xiaobin
Buyers and Sellers in the Weight Loss M&A Market:Without Buying and Selling, There's No Reshuffle
The development of weight-loss drugs is currently one of the hottest topics in the pharmaceutical industry.
December 20, 2024
by Krebs Qin
Pharmaceutical International Cooperation Under the New Drug Policies in China By ChatGPT
The business environment for pharmaceutical companies in China is generally favorable. China has a large population and a growing middle class, which creates a significant demand for healthcare and pharmaceutical products.
September 11, 2023
by ChatGPT/PharmaSources
CPhI Monthly Podcast: M&A strategies in the CDMO sector
This month we discuss what is driving M&A strategies in the pharma space, paying particular attention to how investors regard the potential for the growing but fragmented CDMO sector
June 28, 2021
by cphi-online
TA Associates acquires stake in OmniActive Health Technologies
The company has R&D and manufacturing operations in Pune, Hosur and Thane in India; and sales and distribution operations in the US, Europe, India, Asia, Australia and Latin America.
January 12, 2021
by expresspharma
Value of pharma’s M&A deals remain high, despite COVID-19
Analysts say M&A deals continue to be a core driver of pharma/biopharma industry growth and that 2021 will likely be another year of high deal value.
January 11, 2021
by europeanpharmaceuticalreview
M&As in bio/pharma industry high despite COVID-19: GlobalData
Down only 13 per cent compared with last year, with a total deal value of $228 billion compared with $262 billion in 2020, and almost twice the 2017 total deal value of $126 billion.
December 28, 2020
by expresspharma
Pharma M&A activity up 17 percent year-on-year in H1 of 2020
A new report has highlighted that despite the pandemic, pharma M&A activity rose but deal value fell in the first half of 2020.
November 6, 2020
by europeanpharmaceuticalreview
What’s been happening in pharma? - Updates on M&A, Regulatory approvals and collaborations
Key updates in June are summarized here, along with some of the latest industry announcements on new partnerships, M&As and regulatory approvals.
June 29, 2020
by Sarah Harding
What’s been happening in pharma? - Updates on COVID pandemic
Pharma news in the second half of June continues to be dominated by the COVID pandemic.
June 29, 2020
by Sarah Harding
10 Predictions on How COVID-19 Will Impact Middle Market M&A
The coronavirus outbreak has impacted just about every aspect of daily life on a global scale, and middle market M&A is no exception.
June 15, 2020
by prnewswire
Life science M&A activity reached $357bn in 2019, report finds
According to new research, M&As within the life science industry reached a high last year and is expected to continue its growth in 2020.
January 15, 2020
by europeanpharmaceuticalreview